Immune Repertoire Insights That Advance Precision Medicine
Unveil the adaptive immune response with TCR/BCR profiling and single-cell paired-chain V(D)J analysis for biomarker discovery and therapeutic development
Resolve patient-specific immune signals for cancer, autoimmunity, infectious disease, and more.
Immune repertoire sequencing provides insights into immune history and diversity, neutralizing antibodies, antigen specificity, and clonal dynamics with the potential to transform overall management of immune-mediated diseases and therapies.
Standard immune repertoire sequencing approaches are limited by subtype restrictions, lack of reproducibility, high error rates, insufficient capture of rare clones, and limited data analysis tools for mapping repertoire diversity and clonality networks.
See why iRepertoire is the most trusted and comprehensive source for immune enlightenment.
Full-stack immune profiling expertise:
From sensitive detection to rich data analysis
We offer a complete suite of adaptive immune receptor profiling and data analysis solutions. Each platform workflow combines proprietary chemistry with optimized analytics to reveal the true diversity of the adaptive immune system.
Bulk TCR/BCR Sequencing with Full 7-Chain Coverage
While other platforms require multiple reactions to profile different receptor chains or limit analysis to DNA or RNA alone, iRepertoire’s dam-PCR technology simultaneously amplifies all seven chains (TCR⍺, TCRβ, TCR𝛾, TCRδ, IgH, IgK, IgL) with UMI-based error correction. The unique capability delivers the complete immune picture your research demands, without compromising on sensitivity or amplification bias.
Single-Cell V(D)J Sequencing
Capture therapeutically relevant cognate TCR or BCR pairing from FACS-isolated single cells with our iPair platform, designed for researchers who need full-length, physically paired sequences without investing in expensive single-cell platforms.
Data Analysis
We’ve analyzed immune repertoires since 2009, publishing landmark studies and supporting dozens of clinical programs. Our scientists don’t just generate data; they partner with you to extract biological meaning and accelerate decision-making.
Bulk TCR/BCR Sequencing with Full 7-Chain Coverage
While other platforms require multiple reactions to profile different receptor chains or limit analysis to DNA or RNA alone, iRepertoire’s dam-PCR technology simultaneously amplifies all seven chains (TCRa, TCRB, TCRy, TCR6, IgH, IgK, IgL) with UMI- based error correction. The unique capability delivers the complete immune picture your research demands, without compromising on sensitivity or amplification bias.
Single-Cell V(D)J Sequencing
Capture therapeutically relevant cognate TCR or BCR pairing from FACS-isolated single cells with our iPair platform, designed for researchers who need full-length, physically paired sequences without investing in expensive single-cell platforms.
Bioinformatics
We’ve analyzed immune repertoires since 2009, publishing landmark studies and supporting dozens of clinical programs. Our scientists don’t just generate data; they partner with you to extract biological meaning and accelerate decision-making.
Precise, cost-effective insights with published validity
across key clinical areas
Our immune repertoire profiling solutions empower discovery, preclinical, and clinical teams across therapeutic areas. See how we enable confident biomarker identification and therapeutic development for each.
Immuno-oncology Therapy Monitoring
Comprehensive TCR/ BCR repertoire and gene expression insights to track treatment response, reveal biomarkers of efficacy or toxicity, and support data-driven clinical decisions.
Cell Therapy Optimization
Cell therapy optimization and quality control with multi-omic immune profiling that validates manufacturing consistency, confirms therapeutic phenotype, and de-risks clinical development.
Infectious Disease Therapeutics
Advance infectious disease therapeutics by mapping rare antigen-specific B- and T-cell responses, defining host immune signatures, and guiding the discovery of vaccines and monoclonal antibodies.
Autoimmune Disease Biomarker Discovery
Uncover autoimmune disease biomarkers by profiling rare B and T-cell clones and immune repertoires-delivering reproducible insights into disease mechanisms, diagnostics, and treatment response prediction.
The iRepertoire difference
Founded by immunologists for immunologists at HudsonAlpha Institute for Biotechnology, we’ve never forgotten that behind every sample is a scientific question that matters. Our technology is sophisticated, but our approach is simple: deliver the most complete, accurate immune profiling data possible, and partner with you to extract biological meaning. Our three main core values set us apart from other companies as we strive to create true partnerships with our customers.
Scientific Partnership, Not Just Service
- Dedicated PhD-level scientists review every project from library prep through data delivery
- Custom assay optimization for your specific research questions
- Collaborative data interpretation and publication support
Quality You Can Defend
- GCLP-compliant Quality Management System
- Batch-level QC with contamination detection and flagging
- Replicate controls in every run for absolute confidence
- Validation documentation ready for regulatory submissions
Flexibility That Accelerates Discovery
- Adapt protocols mid-study as your questions evolve
- Scale from pilot studies to pivotal trials seamlessly
- Support for non-standard sample types and experimental designs
iRepertoire has been the scientists’ choice for immune repertoire analysis, offering accuracy, reproducibility, and actionable insights. We have partnered with top institutions to develop the next generation of immune-based biomarkers and therapeutics. Explore who our partners are or read our publications to learn more about our contributions.
Customer Testimonials
Featured content
Case Studies
Mitigating AIRRseq Challenges in FFPE Tissue Samples with the RepSeq+ Immune Repertoire Intelligence Platform
Predicting and measuring patient response to cell therapy with single cell TCR sequencing
Webinars
March 6, 2025
Evaluating Gene Expression and TCR Repertoire Dynamics in γδ T Cell Therapies